Partner Content Partner Content Cello Health announces launch of new business Cello Health L... A new social media insight and analytics offering
News GSK asthma hope depemokimab works in second indication GSK's experimental IL-5 inhibitor depemokimab has shown its potential in a pair of phase 3 trials in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.
